Gilead To Explore Trodelvy Drug Against Different Cancers After $21B Merger With Immunomedics
September 14, 2020 at 05:50 AM EDT
After initial reports emerged on Saturday about a potential acquisition deal, Gilead Sciences Inc. confirmed that it's set to purchase Immunomedics Inc.
